Avadel Pharmaceuticals (AVDL) Short Interest Ratio & Short Volume $10.11 -0.20 (-1.94%) (As of 10:34 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Avadel Pharmaceuticals Short Interest DataAvadel Pharmaceuticals (AVDL) has a short interest of 9.79 million shares. This marks a 11.12% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.3, indicating that it would take 8.3 days of the average trading volume of 1.19 million shares to cover all short positions.Current Short Interest9,790,000 sharesPrevious Short Interest8,810,000 sharesChange Vs. Previous Month+11.12%Dollar Volume Sold Short$108.28 millionShort Interest Ratio8.3 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares96,362,000 sharesPercentage of Shares Shorted10.16%Today's Trading Volume92,037 sharesAverage Trading Volume1,192,497 sharesToday's Volume Vs. Average8% Short Selling Avadel Pharmaceuticals? Sign up to receive the latest short interest report for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVDL Short Interest Over TimeAVDL Days to Cover Over TimeAVDL Percentage of Float Shorted Over Time Ad DTIForced out of retirement by these trades You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changedMake sure to check out Gamma Pockets HERE while it’s still widely available Avadel Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20249,790,000 shares $108.28 million +11.1%N/A8.3 $11.06 11/15/20248,810,000 shares $96.12 million -6.8%N/A7.5 $10.91 10/31/20249,450,000 shares $146.19 million -7.3%N/A10.1 $15.47 10/15/202410,190,000 shares $134.51 million -7.1%N/A11.5 $13.20 9/30/202410,970,000 shares $143.82 million -5.9%N/A11.8 $13.11 9/15/202411,660,000 shares $159.74 million -2.1%N/A9.2 $13.70 Get the Latest News and Ratings for AVDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/202411,910,000 shares $180.67 million +1.2%N/A9.4 $15.17 8/15/202411,770,000 shares $180.67 million +3.5%N/A9.8 $15.35 7/31/202411,370,000 shares $185.79 million -5.5%N/A8.7 $16.34 7/15/202412,030,000 shares $199.22 million +42.0%N/A9.4 $16.56 6/30/20248,470,000 shares $119.09 million +17.6%N/A6.3 $14.06 6/15/20247,200,000 shares $113.83 million +11.1%N/A7.2 $15.81 5/31/20246,480,000 shares $103.36 million +14.1%N/A6.9 $15.95 5/15/20245,680,000 shares $91.39 million +18.3%N/A4.5 $16.09 4/30/20244,800,000 shares $87.17 million -54.8%N/A3.8 $18.16 4/15/202410,610,000 shares $0.00 +2.1%N/A8.7 $0.00 3/31/202410,390,000 shares $175.49 million -0.8%N/A8.4 $16.89 3/15/202410,470,000 shares $166.68 million -2.5%N/A8.2 $15.92 2/29/202410,740,000 shares $137.26 million +21.2%N/A8.5 $12.78 2/15/20248,860,000 shares $125.81 million +4.5%N/A9.2 $14.20 1/31/20248,480,000 shares $122.03 million +30.1%N/A9.2 $14.39 1/15/20246,520,000 shares $96.50 million +26.6%N/A7.7 $14.80 12/31/20235,150,000 shares $72.72 million +2.2%N/A6.8 $14.12 12/15/20235,040,000 shares $70.51 million +6.1%N/A7.5 $13.99 11/30/20234,750,000 shares $54.82 million -0.4%N/A7.6 $11.54 11/15/20234,770,000 shares $52.09 million +19.3%N/A8.3 $10.92 10/31/20234,000,000 shares $39.44 million +4.4%N/A6.9 $9.86 10/15/20233,830,000 shares $40.29 million +0.8%N/A6.8 $10.52 9/30/20233,800,000 shares $39.14 million +13.8%N/A6.6 $10.30 9/15/20233,340,000 shares $40.98 million +28.0%N/A5 $12.27 8/31/20232,610,000 shares $35.26 million -15.3%N/A3.5 $13.51 8/15/20233,080,000 shares $42.38 million -1.0%N/A3.9 $13.76 7/31/20233,110,000 shares $43.85 million -8.5%N/A3.7 $14.10 7/15/20233,400,000 shares $52.33 million -8.6%N/A3.4 $15.39 6/30/20233,720,000 shares $61.31 million -21.4%N/A3.8 $16.48 6/15/20234,730,000 shares $70.00 million +16.8%N/A4.6 $14.80 5/31/20234,050,000 shares $56.09 million +20.9%N/A4.4 $13.85 5/15/20233,350,000 shares $48.61 million -13.9%N/A3.7 $14.51 4/30/20233,890,000 shares $40.77 million +4.6%N/A4.5 $10.48 4/15/20233,720,000 shares $36.87 million +24.0%N/A5.8 $9.91If you see ONE chart today… make it this one (Ad)$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Goldman Sachs. This investment is driving an A.I. boom that’s being felt across many industries… Including a specific group of energy tickers since A.I. data centers use a massive amount of power. One of those tickers is CEG, up nearly 600% in the last 3 years… Combined with the upcoming presidential election, we have the recipe for a major shakeup in the market. You see, each time the U.S. elects a new president, one overlooked part of the energy sector tends to see a big move. Fact is… this energy niche is BOOMING.And expects this underappreciated niche to continue rallying well into 2026. 3/31/20233,000,000 shares $27.48 million -24.1%N/A4.9 $9.16 3/15/20233,950,000 shares $36.26 million -0.3%6.9%9 $9.18 2/28/20233,960,000 shares $39.40 million +0.3%7.3%7.9 $9.95 2/15/20233,950,000 shares $33.58 million +7.9%7.2%7.5 $8.50 1/31/20233,660,000 shares $27.54 million +9.6%6.5%6.1 $7.53 1/15/20233,340,000 shares $22.98 million -17.5%5.9%5.4 $6.88 12/30/20224,050,000 shares $29.00 million +3.3%7.1%6.8 $7.16 12/15/20223,920,000 shares $26.93 million +0.8%6.9%5.3 $6.87 11/30/20223,890,000 shares $35.67 million -2.5%6.9%5.7 $9.17 11/15/20223,990,000 shares $32.12 million -1.0%7.0%6.1 $8.05 10/31/20224,030,000 shares $26.56 million -1.2%7.3%7 $6.59 10/15/20224,080,000 shares $24.60 million +7.9%7.4%6.7 $6.03 9/30/20223,780,000 shares $18.94 million -4.6%6.9%5.3 $5.01 9/15/20223,960,000 shares $23.64 million +2.1%7.2%5.4 $5.97 8/31/20223,880,000 shares $25.76 million -14.0%7.1%4.8 $6.64 8/15/20224,510,000 shares $30.98 million -4.0%8.2%1.2 $6.87 7/31/20224,700,000 shares $22.23 million -12.2%8.7%1.2 $4.73 7/15/20225,350,000 shares $25.25 million -5.5%13.5%1.3 $4.72 6/30/20225,660,000 shares $13.81 million -5.0%14.2%1.4 $2.44 6/15/20225,960,000 shares $13.77 million +42.6%15.0%1.6 $2.31 5/31/20224,180,000 shares $9.24 million +7.2%8.3%1.1 $2.21 5/15/20223,900,000 shares $14.82 million -6.0%7.8%6.4 $3.80 4/30/20224,150,000 shares $20.75 million +4.8%8.2%7 $5.00 4/15/20223,960,000 shares $26.85 million -15.2%7.9%10 $6.78 3/31/20224,670,000 shares $31.90 million +7.1%9.3%11 $6.83 3/15/20224,360,000 shares $30.04 million -3.8%8.7%10.1 $6.89 2/28/20224,530,000 shares $36.51 million -11.2%9.1%10.4 $8.06 2/15/20225,100,000 shares $35.65 million +4.5%10.2%11.7 $6.99 1/31/20224,880,000 shares $29.38 million +1.7%9.8%10.3 $6.02 1/15/20224,800,000 shares $31.01 million +4.6%9.6%9.3 $6.46 12/31/20214,590,000 shares $37.09 million +10.3%9.1%6.5 $8.08 12/15/20214,160,000 shares $31.12 million -2.1%8.2%5.7 $7.48 11/30/20214,250,000 shares $38.08 million -11.1%8.4%5.8 $8.96 11/15/20214,780,000 shares $52.72 million +29.9%9.4%6.8 $11.03 10/29/20213,680,000 shares $35.73 million +3.7%6.8%5.5 $9.71 10/15/20213,550,000 shares $35.46 million +2.3%6.5%6.2 $9.99 9/30/20213,470,000 shares $34.01 million -7.0%6.4%9.7 $9.80 9/15/20213,730,000 shares $29.24 million +1.4%6.8%12.7 $7.84 8/31/20213,680,000 shares $30.51 million +1.1%6.8%14.1 $8.29 8/13/20213,640,000 shares $29.37 million -6.4%6.7%14.1 $8.07 7/30/20213,890,000 shares $30.23 million No Change7.2%13.9 $7.77 7/15/20213,890,000 shares $26.18 million +0.5%7.2%14.3 $6.73 6/30/20213,870,000 shares $26.05 million -8.7%7.1%14.4 $6.73 6/15/20214,240,000 shares $31.76 million +0.2%7.8%17.3 $7.49 5/28/20214,230,000 shares $32.53 million +7.1%7.8%15.7 $7.69 5/14/20213,950,000 shares $31.52 million +1.0%N/A11.4 $7.98 4/30/20213,910,000 shares $30.69 million -2.0%N/A9.1 $7.85 4/15/20213,990,000 shares $35.03 million +1.8%N/A8.1 $8.78 3/31/20213,920,000 shares $34.77 million -8.8%N/A7.8 $8.87 3/15/20214,300,000 shares $42.01 million -6.1%N/A7.5 $9.77If you see ONE chart today… make it this one (Ad)$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Goldman Sachs. This investment is driving an A.I. boom that’s being felt across many industries… Including a specific group of energy tickers since A.I. data centers use a massive amount of power. One of those tickers is CEG, up nearly 600% in the last 3 years… Combined with the upcoming presidential election, we have the recipe for a major shakeup in the market. You see, each time the U.S. elects a new president, one overlooked part of the energy sector tends to see a big move. Fact is… this energy niche is BOOMING.And expects this underappreciated niche to continue rallying well into 2026. 2/26/20214,580,000 shares $38.75 million +21.5%N/A8.1 $8.46 2/12/20213,770,000 shares $34.27 million +9.3%N/A6.9 $9.09 1/29/20213,450,000 shares $26.19 million -10.4%N/A6.7 $7.59 1/15/20213,850,000 shares $25.45 million -3.3%N/A8.1 $6.61 12/31/20203,980,000 shares $26.63 million -3.2%N/A8.7 $6.69 12/15/20204,110,000 shares $30.87 million -6.4%N/A8.6 $7.51 11/30/20204,390,000 shares $32.79 million +2.3%N/A7.3 $7.47 11/15/20204,290,000 shares $27.67 million +3.1%N/A5.8 $6.45 10/30/20204,160,000 shares $21.59 million +4.5%N/A5.3 $5.19 10/15/20203,980,000 shares $21.25 million -1.5%N/A5 $5.34 9/30/20204,040,000 shares $20.36 million -36.2%N/A4.8 $5.04 9/15/20206,330,000 shares $33.23 million -0.5%N/A7.2 $5.25 8/31/20206,360,000 shares $46.49 million +4.8%N/A8.5 $7.31 8/14/20206,070,000 shares $48.01 million +9.6%N/A9.5 $7.91 7/31/20205,540,000 shares $43.38 million +10.1%N/A8.4 $7.83 7/15/20205,030,000 shares $38.53 million -2.7%N/A5.6 $7.66 6/30/20205,170,000 shares $41.05 million +13.9%N/A5.8 $7.94 6/15/20204,540,000 shares $38.68 million -11.7%N/A5.4 $8.52 5/29/20205,140,000 shares $41.53 million -8.9%N/A5.8 $8.08 5/15/20205,640,000 shares $45.57 million -14.4%N/A6.1 $8.08 4/30/20206,590,000 shares $68.40 million +1.4%19.0%7 $10.38 4/15/20206,500,000 shares $64.22 million +47.7%18.8%8.9 $9.88 3/31/20204,400,000 shares $43.25 million +11.3%12.7%5.7 $9.83 3/13/20203,953,100 shares $37.55 million -43.9%11.4%5.5 $9.50 2/28/20207,050,000 shares $49.07 million +12.6%20.4%8.4 $6.96 2/14/20206,260,000 shares $53.65 million -8.1%N/A7.8 $8.57 1/31/20206,810,000 shares $70.48 million +2.1%18.9%10.2 $10.35 1/15/20206,670,000 shares $50.29 million -3.9%N/A10.4 $7.54 12/31/20196,940,000 shares $47.82 million +2.4%N/A12 $6.89 AVDL Short Interest - Frequently Asked Questions What is Avadel Pharmaceuticals' current short interest? Short interest is the volume of Avadel Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 9,790,000 shares of AVDL short. Learn More on Avadel Pharmaceuticals' current short interest. What is a good short interest ratio for Avadel Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVDL shares currently have a short interest ratio of 8.0. Learn More on Avadel Pharmaceuticals's short interest ratio. Which institutional investors are shorting Avadel Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Avadel Pharmaceuticals: Jane Street Group LLC, Wolverine Trading LLC, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Vestal Point Capital LP, Walleye Capital LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Avadel Pharmaceuticals' short interest increasing or decreasing? Avadel Pharmaceuticals saw a increase in short interest in November. As of November 30th, there was short interest totaling 9,790,000 shares, an increase of 11.1% from the previous total of 8,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Avadel Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Avadel Pharmaceuticals: Biohaven Ltd. (7.75%), Apellis Pharmaceuticals, Inc. (17.53%), Immunovant, Inc. (20.39%), Scholar Rock Holding Co. (15.76%), Avidity Biosciences, Inc. (12.52%), Organon & Co. (5.32%), PTC Therapeutics, Inc. (5.96%), Verona Pharma plc (7.91%), Rhythm Pharmaceuticals, Inc. (10.36%), MoonLake Immunotherapeutics (15.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Avadel Pharmaceuticals stock? Short selling AVDL is an investing strategy that aims to generate trading profit from Avadel Pharmaceuticals as its price is falling. AVDL shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avadel Pharmaceuticals? A short squeeze for Avadel Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVDL, which in turn drives the price of the stock up even further. How often is Avadel Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVDL, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies BHVN Short Interest APLS Short Interest IMVT Short Interest SRRK Short Interest RNA Short Interest OGN Short Interest PTCT Short Interest VRNA Short Interest RYTM Short Interest MLTX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVDL) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avadel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
